NovoCure NVCR Income Statement (2014-2026)

NASDAQ NVCR
$16.49 -0.36 (-2.14%)
As of: Sep 9, 2026 · 11:19 AM EDT
Reported Financials

NovoCure Quarterly Income Statement

Periods 48 quarters
Latest Jun 2026

NovoCure reported revenue of $183.58M and net income of -$15.66M for the quarter ended Jun 2026, up 15.6% year over year. This income statement covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
133.61M133.21M137.55M140.87M131.00M128.43M122.18M126.05M127.32M133.78M138.50M150.36M155.09M161.27M154.99M158.81M167.20M174.35M174.06M183.58M
Cost of RevenueCost of Rev
30.21M29.69M27.73M28.50M29.75M28.89M29.61M34.02M32.09M32.56M33.69M34.65M35.37M33.47M38.52M41.47M44.73M42.16M38.93M41.11M
Gross Profit
103.40M103.53M109.82M112.36M101.25M99.54M92.57M92.03M95.23M101.23M104.81M115.70M119.72M127.80M116.47M117.33M122.47M132.19M135.13M142.48M
Operating items
Research & DevelopmentR&D
48.14M56.93M42.23M57.08M51.96M54.82M59.70M58.49M57.96M58.05M55.21M56.62M59.83M67.41M55.79M57.07M58.55M68.66M58.36M61.68M
Selling, General & AdministrativeSG&A
31.23M31.01M30.51M31.67M32.51M38.07M41.94M40.78M41.89M39.45M39.53M37.71M40.10M72.48M44.77M43.95M45.92M43.02M85.85M39.91M
Other Operating ExpensesOther Opex
32.58M38.98M37.88M44.75M41.40M49.63M51.17M55.43M53.62M55.44M51.60M54.95M51.88M51.21M53.78M55.83M54.03M60.91M58.34M51.45M
Operating ExpensesOpex
111.95M126.92M110.63M133.49M125.86M142.52M152.82M154.69M153.47M152.94M146.33M149.28M151.81M191.10M154.34M156.85M158.50M172.59M202.55M153.04M
Operating IncomeOp. Inc
-8.55M-23.40M-0.81M-21.13M-24.61M-42.98M-60.25M-62.66M-58.24M-51.72M-41.52M-33.58M-32.09M-63.30M-37.87M-39.52M-36.02M-40.39M-67.42M-10.56M
EBIT
-8.55M-23.40M-0.81M-21.13M-24.61M-42.98M-60.25M-62.66M-58.24M-51.72M-41.52M-33.58M-32.09M-63.30M-37.87M-39.52M-36.02M-40.39M-67.42M-10.56M
Non-operating items
Non Operating Interest Expenses
1.98M2.17M1.71M2.23M
Interest & Investment IncomeInt & Inv Inc
-1.98M-2.17M1.19M18.53M9.17M8.76M10.02M18.09M9.88M10.85M10.51M19.76M7.57M4.54M6.00M-0.56M-1.84M-1.89M
Net income details
EBT
-10.53M-25.57M-2.52M-23.36M-23.42M-32.56M-51.08M-53.90M-48.22M-38.53M-31.64M-22.73M-21.59M-55.21M-30.30M-34.98M-30.02M-40.95M-69.26M-12.45M
Tax ProvisionsTaxes
2.59M0.89M2.13M0.65M3.16M4.75M1.98M3.51M1.26M8.54M7.12M10.65M8.98M10.72M4.02M5.16M7.25M-16.45M1.88M3.21M
Profit After TaxPAT
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.48M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Income from Continuing OperationsIncome (Continuing)
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.48M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Consolidated Net IncomeConsol Net Inc.
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.48M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Income towards Parent CompanyParent Net Inc
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.48M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Net Income towards Common StockholdersNet Income
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.48M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Additional items
EPS (Basic)
-0.13-0.26-0.04-0.23-0.25-0.36-0.50-0.54-0.46-0.44-0.36-0.31-0.28-0.61-0.31-0.36-0.33-0.22-0.62-0.13
EPS (Diluted)
-0.13-0.26-0.04-0.23-0.25-0.36-0.50-0.54-0.46-0.44-0.36-0.31-0.28-0.61-0.31-0.36-0.33-0.22-0.62-0.13
Shares Outstanding
103.73M103.43M104.19M104.63M104.88M104.66M105.67M106.29M106.77M106.39M107.27M107.70M108.25M107.83M110.28M111.57M111.91M111.47M114.15M116.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
103.73M103.43M104.19M104.63M104.88M104.66M105.67M106.29M106.77M106.39M107.27M107.70M108.25M107.83M110.28M111.57M111.91M111.47M114.15M116.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
103.82M103.97M104.56M104.73M104.94M105.05M106.19M106.61M106.75M107.08M107.60M108.01M108.10M108.52M111.48M111.80M111.98M112.49M115.82M116.44M
EBITDA
-8.55M-23.40M-0.81M-21.13M-24.61M-42.98M-60.25M-62.66M-58.24M-51.72M-41.52M-33.58M-32.09M-63.30M-37.87M-39.52M-36.02M-40.39M-67.42M-10.56M
Interest ExpensesInt Expense
1.98M2.17M1.71M2.23M
Tax Rate
-24.60%-3.46%-84.77%-2.79%-13.49%-14.57%-3.88%-6.52%-2.62%-22.18%-22.50%-46.84%-41.63%-19.41%-13.28%-14.75%-24.14%40.18%-2.71%-25.75%